Picchio Gaston Insider Trades

Insider Trading History

Track insider trading activity for Picchio Gaston. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Arbutus Biopharma
Arbutus Biopharma ABUS
Chief Development Officer
Holding Value $1.12M 256,500 shares
Last Trade
Jan 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$721k 256,500 shares
$2.81
$4.35
Arbutus Biopharma
Arbutus Biopharma ABUS
Chief Development Officer
Holding Value $1.09M 250,000 shares
Last Trade
Feb 13, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.08M 250,000 shares
$4.33
$4.35
Arbutus Biopharma
Arbutus Biopharma ABUS
Chief Development Officer
Holding Value $218k 50,000 shares
Last Trade
Sep 23, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$147k 50,000 shares
$2.94
$4.35
Arbutus Biopharma
Arbutus Biopharma ABUS
Chief Development Officer
Holding Value $653k 150,000 shares
Last Trade
Feb 17, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$503k 150,000 shares
$3.35
$4.35
Arbutus Biopharma
Arbutus Biopharma ABUS
Chief Development Officer
Holding Value $598k 137,500 shares
Last Trade
Mar 01, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$628k 137,500 shares
$4.57
$4.35
Arbutus Biopharma
Arbutus Biopharma ABUS
Chief Development Officer
Holding Value $870k 200,000 shares
Last Trade
Oct 08, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.88M 200,000 shares
$9.38
$4.35

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up